Exploring Reproductive Health Among Women in Somaliland
PROMISE
1 other identifier
observational
808
1 country
1
Brief Summary
Somaliland faces persistently high burdens of maternal and perinatal mortality, with limited population-based data on pregnancy complications, sociocultural influence on maternal health, and women's reproductive health needs across the continuum of pregnancy, childbirth, and postpartum. Existing maternal near-miss (MNM) tools are largely facility-based, and evidence of postpartum contraceptive uptake and interventions remains scarce. In response, the objective of this study is to unfold the physical, cultural, and psychosocial strengths and challenges experienced by women in Somaliland during pregnancy, childbirth, and the postpartum period; to examine how these factors interact to influence pregnancy outcomes and women's ability to achieve future reproductive health goals; and to pilot how these insights can inform the co-creation of context-appropriate health materials. The PROMISE study is a community-based longitudinal pregnancy cohort in Hargeisa, Somaliland, including approximately 800 pregnant women \<28 weeks of gestation recruited from randomly selected sub-districts. Women will be followed up at three time points (early pregnancy, late pregnancy, and postpartum) using questionnaires and clinical measurements. A MNM tool will be adapted through a Delphi process, and its validity will be tested using the cohort. The cohort findings will inform a co-creation process to develop postpartum contraceptive counselling materials to be pilot-tested for feasibility, acceptability, and preliminary effects. This protocol responds to major evidence gaps in fragile and low-resource contexts, and aims to generate contextually grounded knowledge and co-created interventions to strengthen maternal health policy, practice, and reproductive agency in Somaliland and beyond.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2025
CompletedFirst Submitted
Initial submission to the registry
February 15, 2026
CompletedFirst Posted
Study publicly available on registry
February 27, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2026
CompletedFebruary 27, 2026
February 1, 2026
1.2 years
February 15, 2026
February 22, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Adverse birth outcomes
A composite of admission to neonatal intensive care unit, mode of birth (vaginal birth, assisted vaginal birth, and cesarean section), postpartum hemorrhage \> 1000 ml, eclampsia, maternal death, stillbirth in 3rd trimester, neonatal death within one and seven days, preterm birth \< week 37, and low birth weight \< 2000 grams.
Assessed 1 to 3 months post partum
Secondary Outcomes (10)
Antenatal care visits
Assessed between gestational age 36 and birth as well as between 1 to 3 months postpartum
Proportion of pregnant women with hypertensive disorders of pregnancy (HDP)
Assessed between gestational age 36 and birth as well as between 1 to 3 months postpartum
Proportion of pregnant women with Gestational Diabetes
Assessed between gestational age 36 and birth as well as between 1 to 3 months postpartum
Postpartum depression
One to three months postpartum
Social support
Assessed between gestational age 36 and birth
- +5 more secondary outcomes
Eligibility Criteria
All pregnant women residing in randomly selected subdistricts of Hargeisa, Somaliland.
You may qualify if:
- Pregnant woman
- Gestational age less than 28 weeks at the time of recruitment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Hargeisa
Hargeisa, Maroodijeeh, +252, Somalia
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 15, 2026
First Posted
February 27, 2026
Study Start
January 1, 2025
Primary Completion
March 31, 2026
Study Completion
March 31, 2026
Last Updated
February 27, 2026
Record last verified: 2026-02